NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |